Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2019-06-12 2017-03-11
Drug Identification Number 01979574 01979574
Brand name APO-GEMFIBROZIL CAP 300MG USP APO-GEMFIBROZIL CAP 300MG USP
Common or Proper name GEMFIBROZIL GEMFIBROZIL
Company Name APOTEX INC APOTEX INC
Ingredients GEMFIBROZIL GEMFIBROZIL
Strength(s) 300 MG 300 MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C10AB C10AB
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-10-09 2014-10-09
Estimated end date Unknown Unknown
Actual end date 2019-06-03
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments DISCONTINUED
Health Canada comments